Brief: Biofrontera Q4 Preliminary Revenue Between EUR 10.2 Mln And EUR 10.4 Mln
Jan 13 (Reuters) - BIOFRONTERA AG B8FGn.DE :
* ANNOUNCES PRELIMINARY REVENUE FIGURES FOR FULL YEAR 2021
* PRELIMINARY UNAUDITED REVENUE FOR PERIOD JANUARY 1 TO
DECEMBER
31, 2021 IS ANTICIPATED TO BE IN RANGE OF EUR 28.7 MILLION TO
EUR 28.9 MILLION COMPARED TO EUR 30.3 MILLION IN 2020
* TOTAL REVENUE IN Q4 WAS BETWEEN EUR 10.2 AND EUR 10.4
MILLION
* REVENUE GENERATED FROM PRODUCT SALES FOR FULL YEAR 2021
WERE
BETWEEN EUR 28.6 MILLION AND 28.8 MILLION COMPARED TO EUR 23.9
MILLION IN 2020
Source text for Eikon: ID:nPexz8WzKa
Further company coverage: B8FGn.DE
(Gdansk Newsroom)
((Gdansk.Newsroom@thomsonreuters.com;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million